These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9488202)

  • 21. Antithrombotic effects of a platelet fibrinogen receptor antagonist in a canine model of carotid artery thrombosis.
    Willette RN; Sauermelch CF; Rycyna R; Sarkar S; Feuerstein GZ; Nichols AJ; Ohlstein EH
    Stroke; 1992 May; 23(5):703-11. PubMed ID: 1605806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sildenafil improves coronary artery patency in a canine model of platelet-mediated cyclic coronary occlusion after thrombolysis.
    Lewis GD; Witzke C; Colon-Hernandez P; Guerrero JL; Bloch KD; Semigran MJ
    J Am Coll Cardiol; 2006 Apr; 47(7):1471-7. PubMed ID: 16580539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporary and partial inhibition of platelets by SM-20302 prevents coronary artery thrombosis in a chronic canine model.
    Huang J; Rebello SS; Rosenberg LA; Kaneko M; Sakurama T; Lucchesi BR
    Eur J Pharmacol; 1999 Feb; 366(2-3):203-13. PubMed ID: 10082201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different effects of calcium antagonists, nitrates, and beta-blockers on platelet function. Possible importance for the treatment of unstable angina.
    Knight CJ; Panesar M; Wilson DJ; Chronos NA; Patel D; Fox K; Goodall AH
    Circulation; 1997 Jan; 95(1):125-32. PubMed ID: 8994427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronotropic effects of azelnidipine, a slow- and long-acting dihydropyridine-type calcium channel blocker, in anesthetized dogs: a comparison with amlodipine.
    Fujisawa M; Yorikane R; Chiba S; Koike H
    J Cardiovasc Pharmacol; 2009 Apr; 53(4):325-32. PubMed ID: 19295444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiplatelet effect of amlodipine: a possible mechanism through a nitric oxide-mediated process.
    Chou TC; Li CY; Yen MH; Ding YA
    Biochem Pharmacol; 1999 Nov; 58(10):1657-63. PubMed ID: 10535758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abciximab treatment in vitro after aspirin treatment in vivo has additive effects on platelet aggregation, ATP release, and P-selectin expression.
    Scazziota A; Altman R; Rouvier J; Gonzalez C; Ahmed Z; Jeske WP; Walenga JM; Fareed J
    Thromb Res; 2000 Dec; 100(6):479-88. PubMed ID: 11152927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition by nitroglycerin of canine platelet aggregation and cyclic flow reductions in stenosed coronary arteries.
    Tanaka T; Morishima Y; Watanabe K; Takahashi M; Shibano T
    Methods Find Exp Clin Pharmacol; 1995 Dec; 17(10):693-700. PubMed ID: 9053590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined inhibitory effects of aspirin and ethanol on adrenaline exacerbation of acute platelet thrombus formation in stenosed canine coronary arteries.
    Keller JW; Folts JD
    Cardiovasc Res; 1990 Mar; 24(3):191-7. PubMed ID: 2346953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of MDL 28,133A, a 5-HT2 receptor antagonist, on platelet aggregation and coronary thrombosis in dogs.
    Hsieh CP; Sakai K; Bruns GC; Dage RC
    J Cardiovasc Pharmacol; 1994 Nov; 24(5):761-72. PubMed ID: 7532754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High dose intravenous aspirin, not low dose intravenous or oral aspirin, inhibits thrombus formation and stabilizes blood flow in experimental coronary vascular injury.
    Mickelson JK; Hoff PT; Homeister JW; Fantone JC; Lucchesi BR
    J Am Coll Cardiol; 1993 Feb; 21(2):502-10. PubMed ID: 8426017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo characterization of a calcium modulator of the diphenylalkylamine type with selective coronary dilatory properties.
    Caldirola P; Monteil A; Zandberg P; Mannhold R; Timmerman H
    Arzneimittelforschung; 1997 Nov; 47(11):1211-8. PubMed ID: 9428976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist.
    Mousa SA; Bozarth JM; Forsythe MS; Jackson SM; Leamy A; Diemer MM; Kapil RP; Knabb RM; Mayo MC; Pierce SK
    Circulation; 1994 Jan; 89(1):3-12. PubMed ID: 8281661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antithrombotic activity of the phosphodiesterase III inhibitor pelrinone in a canine model of coronary artery thrombosis: enhancement of efficacy with concurrent alpha 2-adrenergic antagonism.
    Kitzen JM; McCallum JD; Harvey C; Morin ME
    J Cardiovasc Pharmacol; 1991 Dec; 18(6):777-90. PubMed ID: 1725888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries.
    Yao SK; Ober JC; McNatt J; Benedict CR; Rosolowsky M; Anderson HV; Cui K; Maffrand JP; Campbell WB; Buja LM
    Circ Res; 1992 Jan; 70(1):39-48. PubMed ID: 1727687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of diltiazem on platelet activation and cytosolic calcium during percutaneous transluminal coronary angioplasty.
    Dai H; Chen J; Tao Q; Zhu J; Zhang F; Zheng L; Qiu Y
    Postgrad Med J; 2003 Sep; 79(935):522-6. PubMed ID: 13679549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet inhibition reduces cyclic flow variations and neointimal proliferation in normal and hypercholesterolemic-atherosclerotic canine coronary arteries.
    Anderson HV; McNatt J; Clubb FJ; Herman M; Maffrand JP; DeClerck F; Ahn C; Buja LM; Willerson JT
    Circulation; 2001 Nov; 104(19):2331-7. PubMed ID: 11696474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of coronary artery thrombosis by SIN-1, a donor of nitric oxide.
    Ovize M; de Lorgeril M; Cathignol D; Delaye J; Renaud S
    J Cardiovasc Pharmacol; 1990 Oct; 16(4):641-5. PubMed ID: 1706807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. rLj-RGD3, a novel recombinant toxin protein from Lampetra japonica, prevents coronary thrombosis-induced acute myocardial infarction by inhibiting platelet functions in rats.
    Wang S; Jiang J; Wang Y; Jia Q; Dai S; Wang Y; Lv L; Wang J
    Biochem Biophys Res Commun; 2018 Mar; 498(1):240-245. PubMed ID: 29407168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of amlodipine and enalapril on platelet function in patients with mild to moderate hypertension.
    Hernández-Hernández R; Armas-Padilla MC; Velasco M; Carvajal AR; Armas de Hernández MJ; Guerrero-Pajuelo J; Pacheco B
    Int J Clin Pharmacol Ther; 1999 Jul; 37(7):323-31. PubMed ID: 10442506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.